Literature DB >> 6416075

Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.

S H Swerdlow, J A Habeshaw, L J Murray, H S Dhaliwal, T A Lister, A G Stansfeld.   

Abstract

The clinical, pathologic, and immunologic aspects of malignant lymphoma of centrocytic type (ML,cc) were studied at diagnosis and often at relapse in 18 patients. The typical patient was a middle-aged or older man with adenopathy, often massive splenomegaly, hepatomegaly, marrow involvement, and, not infrequently, peripheral blood involvement. Histopathologically, ML,cc had a diffuse or vaguely nodular growth pattern with, predominantly, cells resembling centrocytes (cleaved follicular center cells) sometimes with admixed small round lymphocytes but with virtually no transformed cells. In 2 cases the neoplastic cells formed a mantle zone around reactive-appearing follicles. Cell suspensions and frozen sections revealed the monoclonal B-cell nature of all but 1 nonmarking case, and the polyclonality of the follicles in the 1 mantle zone case tested. The B cells had some, but not all, characteristics of both normal mantle and follicular center cells when eight nodes were studied with the use of a panel of monoclonal antibodies, peanut lectin, and endogenous alkaline phosphatase activity. Of 13 patients who underwent repeat biopsies, 1 developed a high grade unclassifiable B-cell lymphoma, and 6 had less marked changes. None of 7 patients tested had a change in light chain class. In conclusion, ML,cc is a distinct entity separable from other B-cell lymphomas in which either centrocytes or small round lymphocytes predominate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416075      PMCID: PMC1916376     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies.

Authors:  J H Leech; A D Glick; J A Waldron; J M Flexner; R G Horn; R D Collins
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

2.  Functional markers: a new perspective on malignant lymphomas.

Authors:  E S Jaffe; R C Braylan; K Nanba; M M Frank; C W Berard
Journal:  Cancer Treat Rep       Date:  1977-09

3.  Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.

Authors:  K Nanba; E S Jaffe; R C Braylan; E J Soban; C W Berard
Journal:  Am J Clin Pathol       Date:  1977-11       Impact factor: 2.493

4.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

5.  Nodular lymphoma--evidence for origin from follicular B lymphocytes.

Authors:  E S Jaffe; E M Shevach; M M Frank; C W Berard; I Green
Journal:  N Engl J Med       Date:  1974-04-11       Impact factor: 91.245

6.  Analysis of HLA-D region-associated molecules with monoclonal antibody.

Authors:  D J Charron; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Prolymphocytic leukaemia.

Authors:  D A Galton; J M Goldman; E Wiltshaw; D Catovsky; K Henry; G J Goldenberg
Journal:  Br J Haematol       Date:  1974-05       Impact factor: 6.998

8.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.

Authors:  D T Yu; R J Winchester; S M Fu; A Gibofsky; H S Ko; H G Kunkel
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

9.  Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes).

Authors:  G Tolksdorf; H Stein; K Lennert
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  27 in total

Review 1.  Mantle cell lymphoma with a unique pattern of CD5 expression: a case report with review of the literatures.

Authors:  Toshiki Yamada; Naoe Goto; Hisashi Tsurumi; Katsuyoshi Takata; Yasuharu Sato; Tadashi Yoshino; Hisataka Moriwaki; Yusuke Kito; Tamotsu Takeuchi; Hitoshi Iwata
Journal:  Med Mol Morphol       Date:  2013-10-29       Impact factor: 2.309

Review 2.  Management of mantle cell lymphoma in the elderly: current and potential strategies.

Authors:  Marguerite Vignon; Marie-Dominique Venon; Olivier Hermine; Richard Delarue
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

3.  Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases.

Authors:  D H Wright
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

Review 4.  Mantle cell lymphoma.

Authors:  Stefano A Pileri; Brunangelo Falini
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

5.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

6.  Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.

Authors:  B R Schwartz; G Pinkus; S Bacus; M Toder; D S Weinberg
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

7.  Primary mediastinal clear cell lymphoma of B-cell type.

Authors:  P Möller; B Lämmler; M Eberlein-Gonska; G E Feichter; W J Hofmann; H Schmitteckert; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

8.  Morphometric nuclear analysis of lymphoid cells in center cell lymphomas and in reactive germinal centers.

Authors:  P Tosi; L Leoncini; D Spina; M T del Vecchio
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

9.  Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.

Authors:  N L Harris; L M Nadler; A K Bhan
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

10.  Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).

Authors:  T Al Saati; G Laurent; P Caveriviere; F Rigal; G Delsol
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.